Loading…
Vanda Pharmaceuticals Inc. is projected to rise to $6.92 by 2027, a +11% move from its current price of $6.24. VNDA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $6.11 | $6.24 | $6.37 | +0.02% |
| Jul 15 | $6.06 | $6.24 | $6.43 | +0.05% |
| Jul 16 | $6.02 | $6.24 | $6.47 | +0.07% |
| Jul 17 | $5.99 | $6.25 | $6.51 | +0.09% |
| Jul 18 | $5.96 | $6.25 | $6.55 | +0.12% |
| Jul 19 | $5.94 | $6.25 | $6.58 | +0.14% |
| Jul 20 | $5.91 | $6.25 | $6.61 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.91 | $6.25 | $6.61 | +0.17% |
| Week 2 | $5.79 | $6.26 | $6.77 | +0.33% |
| Week 3 | $5.70 | $6.27 | $6.90 | +0.50% |
| Week 4 | $5.62 | $6.28 | $7.02 | +0.66% |
| Week 5 | $5.56 | $6.29 | $7.12 | +0.83% |
| Week 6 | $5.50 | $6.30 | $7.22 | +1.00% |
| Week 7 | $5.45 | $6.31 | $7.31 | +1.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to address high unmet medical needs worldwide.
Its commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion.
The company was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
VNDA is a healthcare stock currently trading at $6.21 per share. The company has a market capitalization of $373.44M and ranks 3312 by market cap.
The near-term technical picture is neutral, with RSI14 at 50. The 50-day moving average is $6.34 and the 200-day moving average is $6.46, with a support at $5.73 and resistance at $6.64.
The 30-day price range runs from $5.40 to $7.14, reflecting a relatively tight near-term trading band. Forecasts project a bullish trajectory across the coming years, with the 2026 avg at $6.21 (min $5.73, max $8.02; ROI 0; sentiment NEUTRAL) and rising to higher averages in subsequent years, including 2027 at $6.84, 2028 at $7.50, 2029 at $7.64, 2030 at $8.74, 2040 at $18.70, and 2050 at $38.77.
A major floor 15.2% below — a decisive break under it would weaken the trend.
The nearest floor, 8.2% below — buyers have tended to step in here.
The nearest ceiling, 6.4% above — a clean break opens room to run.
A major ceiling 53.2% above — clearing it would confirm fresh momentum.
Key VNDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VNDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.36 | Sell | $6.32 | Sell |
| MA 10 | $6.23 | Buy | $6.25 | Sell |
| MA 20 | $6.07 | Buy | $6.18 | Buy |
| MA 50 | $6.30 | Sell | $6.34 | Sell |
| MA 100 | $6.91 | Sell | $6.53 | Sell |
| MA 200 | $6.51 | Sell | $6.36 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.29 | Neutral |
| Stoch RSI (14) | 45.76 | Neutral |
| CCI (20) | 64.42 | Neutral |
| Williams %R (14) | -46.58 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 4.87 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 53.42 | Neutral |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | 0.23 | Buy |
| Ultimate (7,14,28) | 57.15 | Neutral |
| Momentum (10) | 0.39 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 6.48 | Sell |
| ADX (14) | 12.48 | Neutral |
| ATR (14) | 0.13 | Info |
The near-term picture is NEUTRAL, with RSI14 at 50.
Key moving averages show SMA50 at $6.34 and SMA200 at $6.46, suggesting a tug between short- and longer-term trends.
Support is indicated at $5.73 and resistance at $6.64, while the 30-day range spans $5.40 to $7.14.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.73 | $6.24 | $8.04 | 0% | Neutral | |
| $5.63 | $6.92 | $8.92 | +11% | Neutral | |
| $6.00 | $7.53 | $10.00 | +21% | Bullish | |
| $6.09 | $7.77 | $10.56 | +25% | Bullish | |
| $6.88 | $8.91 | $12.35 | +43% | Bullish | |
| $8.12 | $10.68 | $15.04 | +71% | Bullish | |
| $8.74 | $11.63 | $16.65 | +86% | Bullish | |
| $8.97 | $12.07 | $17.52 | +93% | Bullish | |
| $8.85 | $12.06 | $17.72 | +93% | Bullish | |
| $9.55 | $13.15 | $19.56 | +111% | Bullish | |
| $13.25 | $19.13 | $29.95 | +207% | Bullish | |
| $25.63 | $40.08 | $67.61 | +542% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.73 | $6.24 | $7.42 | +0.00% |
| August 2026 | $5.46 | $6.41 | $7.68 | +2.69% |
| September 2026 | $5.41 | $6.38 | $7.71 | -0.50% |
| October 2026 | $5.27 | $6.25 | $7.61 | -2.05% |
| November 2026 | $5.33 | $6.34 | $7.78 | +1.56% |
| December 2026 | $5.46 | $6.52 | $8.04 | +2.79% |
Click any year to see its month-by-month VNDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VNDA is projected to trade between $5.73 and $8.04, averaging $6.24 — a potential gain of 0% from today's $6.24. Price action looks broadly range-bound.
Vanda Pharmaceuticals Inc.'s 2027 outlook centres on $6.92, within a $5.63 to $8.92 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, VNDA could reach as high as $10.00, with a base case around $7.53 and support toward $6.00 — roughly +21% from $6.24. Momentum favours further upside here.
Expect VNDA to range from $6.09 to $10.56 through 2029. The $7.77 average target implies a +25% move from current prices. That is up +3% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The VNDA price prediction for 2030 points to an average of $8.91 (low $6.88, high $12.35) — a potential gain of +43% on today's $6.24. Momentum favours further upside here.
In 2031, VNDA is projected to trade between $8.12 and $15.04, averaging $10.68 — a potential gain of +71% from today's $6.24. That is up +20% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Vanda Pharmaceuticals Inc.'s 2032 outlook centres on $11.63, within a $8.74 to $16.65 range. That is up +9% on the projected 2031 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2033, VNDA could reach as high as $17.52, with a base case around $12.07 and support toward $8.97 — roughly +93% from $6.24. Buyers look set to stay in control over this stretch.
Expect VNDA to range from $8.85 to $17.72 through 2034. The $12.06 average target implies a +93% move from current prices. That is 0% versus the projected 2033 average. Momentum favours further upside here.
The VNDA price prediction for 2035 points to an average of $13.15 (low $9.55, high $19.56) — a potential gain of +111% on today's $6.24. Buyers look set to stay in control over this stretch.
In 2040, VNDA is projected to trade between $13.25 and $29.95, averaging $19.13 — a potential gain of +207% from today's $6.24. That is up +46% on the projected 2035 average. Momentum favours further upside here.
Vanda Pharmaceuticals Inc.'s 2050 outlook centres on $40.08, within a $25.63 to $67.61 range. That is up +109% on the projected 2040 average. That marks a +542% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in VNDA today (≈ 160.25641 VNDA) could be worth
$6,422.54
+$5,422.54 (+542%) by 2050 · US Dollar
Based on the average projected VNDA price of $40.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VNDAwould be worth at today's price.
$1,000 invested in VNDA on Jul 10, 2025 (≈ 200.400811 VNDA) would be worth
$1,250.5
+$250.5 (+25.1%) today · 1.25× · US Dollar
Based on a VNDA entry price of $4.99 vs. today's $6.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.21 | $1,004.83 | +0.5% |
| 1 month ago | $6.03 | $1,034.83 | +3.5% |
| 3 months ago | $7.22 | $864.27 | -13.6% |
| 6 months ago | $7.41 | $842.11 | -15.8% |
| 1 year ago | $4.99 | $1,250.5 | +25.1% |
| All time (5.0y) ago | $19.48 | $320.33 | -68.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VNDA forecast.
Our base-case forecast reaches $12.00 around 2033.
Implied market cap at $12.00: $721.63M
The multi-year forecast points to a bullish trajectory over the long horizon, with gradual gains through the late 2020s and into the 2030s and beyond.
In 2030 the avg price is projected at $8.74 with a ROI of 40.8 and a bullish sentiment; by 2040 the avg rises to $18.70 with a ROI of 201.1; by 2050 the avg reaches $38.77 with a ROI of 524.2 and a bullish sentiment. Earlier years show steady increases from 2027 onward (avg $6.84 in 2027, $7.50 in 2028, $7.64 in 2029).
These figures are estimates and not guarantees, and actual results can vary with market conditions.
Tap a question to reveal the answer.
2030 min $6.73, avg $8.74, max $12.13, ROI 40.8, sentiment BULLISH.
Forecasts show a bullish trajectory with rising averages (e.g., $6.84 in 2027, $8.74 in 2030, $38.77 in 2050) and ROI up to 524.2, but these are estimates and not guaranteed.
The forecast max in 2050 is $65.57, suggesting a potential near that level if the trend holds.
The 30-day range is $5.40 to $7.14.
Current price is $6.21 and market cap is $373.44M.
Vanda Pharmaceuticals Inc. Community Discussion
0Share your Vanda Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.